Discover what patients, caregivers, and healthcare providers are saying about a disease, treatment, or symptom to truly understand the voice of the patient.
Social media has enabled an unprecedented increase in conversations that can be measured, tracked, and counted as first-person insights. Our team is using these conversations to provide a new layer of insights into our research that reflect the patient’s voice in a candid, first-person manner that allows us to understand the real-world implications of our research like never before.
Our Social Intelligence and Communities team listens to what patients, caregivers, and HCPs have to say in their own words to give them a voice in the process of drug development. This helps us learn how they describe their conditions, what their challenges and frustrations are, what type of information they seek, and allows us to identify behavioral trends and activities, ultimately resulting in better study recruitment strategies.
Social Intelligence studies produced
Understanding the voices of patients and caregivers allows us to speak with them in a language they resonate with.
Working in collaboration with data scientists, therapeutic experts and clinical operations, we use real world data, study protocol and site/country lists to develop queries within our global social intelligence platform. The team monitors, captures and analyzes large volumes of online conversations and consumer digital behavior data to reveal:
Motivations that impact patients’ healthcare decisions
Behaviors (thoughts and feelings) at each phase of the patient journey (pre–post diagnosis)
Potential barriers to clinical study participation and retention
Sentiment related to living with an indication and the current treatment landscape
Conversation trends or the most discussed topics related to a specific indication
Where and when patients consume their news and entertainment
Digital and mobile consumption habits by demographic
We want to give a voice to the real person behind each patient. This gets lost too often, and we work hard to shed light on what’s important to them, what motivates them, and what role does the disease or clinical trial actually play in the patient’s life.
Deb Piaseczynski, Senior Director of Social Intelligence and Communities
When to engage our Social Intelligence experts in your product’s lifecycle?
Phase III- IV of Clinical Development
Once a disease begins to impact the life of the patient and their circle is the moment they really start communicating about it and their treatment on social networks . We then use these insights to inform the language we use at PRA for study recruitment.
We offer several capabilities unique to the commercialized space to help companies monitor and optimize performance and activities among patients, HCPs and KOLs
Social Listening Services
Global Facebook communities
We listen to Facebook conversations to gain a better understanding of patients and caregivers. These communities are also used to conduct polls and surveys, to ask questions and to promote a clinical trial. We can launch a new community within 24-hours and use targeted advertising campaigns to populate a new community. We use geofencing, targeting by country, language, zip code, email address, gender, age, and interests to target Facebook users for community acquisition.
Multi-lingual, 24/7 Social Platform Inflation and Management includes launching a social profile and populating it within weeks, managing incoming and ongoing public and private conversations, and collecting and distributing brand or 3rd party content to keep members engaged.
Brand or Product Sentiment
Reveals emotions and opinions conveyed for a brand or product mentions via positive, negative or neutral sentiment. These may include an initial report, benchmark and ongoing branded real-time dashboard with quarterly reports.
Competitive Digital/Social Analysis
Overview of drug or brand social media usage, sentiment, volume, and more.
Digital Patient Persona
Building on our patient voice reports, this provides a combination of social listening, plus a 360 ° persona that includes media usage, political leanings, personality traits, household makeup and income, device usage, etc.
Custom real-time dashboards coordinating social intelligence learnings across multiple channels or accounts.
KOL Analysis & Management
Analyze KOL social presence to maximize effectiveness of relationships and provide training and content for sharing.
Social listening around specific conferences and indications.
Our people are our greatest strength
Healthcare intelligence (HQ) is what we call PRA’s unique mixture of intellectual expertise, empathy for the patient experience, and passion for…
Healthcare Intelligence: Q&A with Nicole Duffey
After more than 20 years in the clinical development industry, PRA’s Senior Vice President and General Manager Nicole Duffey is just as passionate…
Spotlight on Marty Lee
When you’re seeing patients, you don’t just want to make sure that they’re eligible for a trial. The trial needs to make sense for the patient and…